Kadima Neuropsychiatry Institute in La Jolla, CA expected to serve as clinical model for Hope treatment offerings nationwide Kadima is a leading investigative site for CNS and psychedelic research, having served as the lead site in nearly all major trials in this space Dr. David Feifel, a nationally recognized pioneer in interventional psychiatry to join HOPE as Chief Medical Innovation Officer upon closing Acquisition expected to be accretive to revenue and EBITDA for NRx and HOPE MIAMI, May 13, 2025 /PR ...

Mind Medicine (MindMed) (MNMD) Q1 2025 Earnings Call May 08, 2025 08:00 AM ET Company Participants Stephanie Fagan - Chief Corporate Affairs OfficerRobert Barrow - Director & CEOMatt Wiley - Chief Commercial OfficerDaniel Karlin - Chief Medical OfficerBrian Abrahams - MD & Global Sector Head - Health Care ResearchYesha Patel - Equity Research AssociateElaine Kim - Biotech Equity Research AssociateRudy Li - DirectorSumant Kulkarni - Managing Director Conference Call Participants None - AnalystMichael Okunewi ...

Lifestance Health Group (LFST) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Company Participants Monica Prokocki - Vice President, Investor RelationsDavid Bourdon - CEORyan McGroarty - CFOCraig Hettenbach - Executive DirectorRyan Daniels - Group Head–Healthcare Technology and ServicesRichard Close - Managing DirectorSteve Dechert - AVP Conference Call Participants Jamie Perse - Equity Research AnalystBrian Tanquilut - Equity Research Analyst - Healthcare Services Operator Good day everyone and thank you f ...

The exception to this was young adults ages 18-34. They were both more likely to feel negative about their mental health and less likely to talk about it. Only 41% of young adults felt positive about their mental health, compared with 61% of those ages 55 and older. And over one-third (34%) said a barrier to talking openly about mental health is not having someone to confide in. NEW YORK, May 7, 2025 /PRNewswire/ -- While public attitudes toward mental health are improving, stigma and barriers to care remai ...

MIAMI, May 6, 2025 /PRNewswire/ -- HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology-driven company and wholly-owned subsidiary of NRx Pharmaceuticals, Inc. ("NRx" or the "Company") (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, today announced that it will host an investor event at the Mar-A-Lago Club in Palm Beach, Florida, on Thursday, May 8, 2025, at the invitation of club members. HOPE Therapeutics, Inc. (PRNewsfoto/NRx Pharmaceuticals, Inc.) This discussion is being held to ...

Core Insights - Neuronetics reported strong financial results for Q1 2025, with total revenues of $32.0 million, an 84% increase compared to $17.4 million in Q1 2024, primarily driven by the acquisition of Greenbrook [5][6][10] - The company is on track to achieve positive cash flow by Q3 2025, supported by growth initiatives and operational improvements [4][15] Financial Performance - Total revenues for Q1 2025 were $32.0 million, up 84% from $17.4 million in Q1 2024, with U.S. revenues increasing by 87% to $31.5 million [5][6] - U.S. clinic revenue reached $18.7 million, while treatment session revenue was $9.6 million, both reflecting the impact of the Greenbrook acquisition [8][10] - Gross margin decreased to 49.2% from 75.1% in the previous year, mainly due to the inclusion of Greenbrook's clinic business [9] - Operating expenses rose to $26.8 million, a 35% increase from $19.9 million in Q1 2024, largely due to Greenbrook's administrative costs [9] Operational Highlights - The integration of Greenbrook is progressing well, with significant operational advancements noted [6][15] - The Better Me Provider program is effectively increasing patient treatment rates and therapy initiation speed [4] - Major insurance coverage expansions for adolescent TMS treatment have been achieved, enhancing access for patients aged 15 and older [13][14] Strategic Developments - A secondary offering raised approximately $18.9 million in net proceeds, strengthening the company's financial position [6][15] - The company expects total worldwide revenue for Q2 2025 to be between $36.0 million and $38.0 million, and for the full year 2025, between $149.0 million and $155.0 million [16][17] Leadership Changes - Chief Financial Officer Steve Furlong will retire in March 2026, with a search for his successor already underway [12]

Core Insights - Bread Financial is investing $3 million over three years to enhance mental health support for children in military families, in collaboration with the Bob Woodruff Foundation [1][2] - The initiative aims to address mental health challenges faced by military-connected children, which are exacerbated by frequent relocations and service-related stressors [2][4] - The investment will fund local mental health service providers to improve access to high-quality care for these children and their families [2][8] Company Overview - Bread Financial is a tech-forward financial services company that offers personalized payment, lending, and saving solutions to millions of U.S. consumers [5] - The company has a history of strategic investments aimed at strengthening communities, particularly in supporting military families [2][4] Partnership Details - The partnership with the Bob Woodruff Foundation will utilize the investment to support local mental health service providers through grants [2][8] - More than 70% of the Foundation's Got Your 6 Network partners reported caring for families with children needing mental health services, but only 13% felt they could meet the full demand [2] Program Focus - The funding will support direct clinical mental health care, training for clinicians, and proven programs that promote overall wellbeing and social connection for military-connected children [8]

Teladoc Health (TDOC) Q1 2025 Earnings Call April 30, 2025 04:30 PM ET Company Participants Michael Minchak - Vice President, Investor RelationCharles Divita - CEOMala Murthy - CFODavid Roman - Managing DirectorAlan Chen - VP - Equity ResearchCharles Rhyee - Managing Director Conference Call Participants Jessica Tassan - Senior Equity Research AnalystDaniel Grosslight - Senior Research AnalystEduardo Ron - Analyst Operator Good afternoon. Thank you for attending today's Teladoc Health First Quarter twenty t ...

Financial Data and Key Metrics Changes - First quarter consolidated revenue was $629.4 million, down 3% year over year, but at the high end of the guidance range [20] - Adjusted EBITDA was $58.1 million, representing a margin of 9.2% [20] - Consolidated net loss per share was $0.53, compared to a net loss per share of $0.49 in the same quarter of the previous year [20][21] - Free cash flow was a net outflow of $16 million, an improvement of $11 million compared to the prior year [22] Business Line Data and Key Metrics Changes - Integrated Care segment revenue was $389.5 million, an increase of 3.3% year over year, exceeding the top end of guidance [22] - BetterHelp segment revenue was $239.9 million, down 11% year over year, but above the midpoint of guidance [26] - U.S. Integrated Care segment membership reached 102.5 million, up 12% year over year [24] - Virtual visit volume in the U.S. increased by 7%, while Chronic Care enrollment rose by 3% [24] Market Data and Key Metrics Changes - The international business of Integrated Care showed revenue growth in the mid-teens on a constant currency basis [13][24] - BetterHelp served over 1 million unique users globally in 2024, with 40% being new to therapy [8] Company Strategy and Development Direction - The acquisition of Uplift aims to enhance the BetterHelp segment's position in virtual mental health services [6][7] - The company is focused on expanding its international markets and enhancing product offerings, including new pricing models [11] - The strategy includes leveraging BetterHelp's consumer expertise to provide more options for mental health care [7] Management's Comments on Operating Environment and Future Outlook - The healthcare industry faces challenges from medical cost trends and mental health issues, but these dynamics also present opportunities [16] - The broader economic environment is being monitored closely, with signs of weakening business and consumer sentiment [18] - The company remains on track with its 2025 revenue outlook and is optimistic about future growth potential despite macro uncertainties [19] Other Important Information - The company has a strong cash position with nearly $1.2 billion in cash and cash equivalents [38] - The acquisition of Uplift was valued at $30 million in cash, with potential additional earn-out consideration [32] Q&A Session Summary Question: Impact of shorter duration contracts on BetterHelp - Management noted that the weekly offering has led to stronger conversion rates but also higher churn, resulting in a net positive effect [41][44] Question: Evaluation of BetterHelp network's payer coverage - Management clarified that the focus was on technical capabilities and that they paused payer contracts to avoid mixed signals during the Uplift acquisition [47][49] Question: Trends in BetterHelp member growth and revenue per member - Management explained that while revenue per member has declined, the significant increase in membership provides opportunities for upselling additional services [56][58] Question: BetterHelp margin improvement expectations - Management indicated that the second half of the year would see revenue growth driven by international efforts and insurance initiatives, with a planned pullback in ad spend [75][77] Question: Customer acquisition cost trends - Management reported stable customer acquisition costs, with favorable trends due to improved conversion rates from the weekly offering [85][86] Question: Cost-saving opportunities in technology and G&A - Management emphasized ongoing efforts to streamline costs, with a focus on technology and development spending being down year over year [92][95]